VANCOUVER, BC, June 29,
2022 /PRNewswire/ - WELL Health Technologies Corp.
(TSX: WELL) ("WELL" or the "Company"), a digital health company
focused on positively impacting health outcomes by leveraging
technology to empower healthcare practitioners and their patients
globally, is pleased to provide an update regarding its majority
owned subsidiary, Wisp. As the fastest, most accessible sexual and
reproductive telehealth service in the U.S. today, Wisp is
committed to providing specialized services to address the most
intimate of issues from bacterial vaginosis to herpes to birth
control and emergency contraception.
In light of the U.S. Supreme Court's verdict on Roe v. Wade,
Wisp is announcing its commitment to helping people get the
healthcare they need and will be donating 1% of proceeds from its
emergency contraceptive and birth control categories for the next 2
months in addition to matching employee donations. Proceeds will be
donated to Wisp's long-standing partners, Sexuality Information and
Education Council of the United
States (SIECUS) which advances sex education through
advocacy, policy and coalition building and The New York Birth
Control Access Project (NYBCAP) which helps break down barriers and
increases access, so all New Yorkers are able to obtain the birth
control they need. Wisp is also paying travel costs for employees
that need support with reproductive health services.
"Since launching in 2018, Wisp's mission has always been to make
sexual and reproductive healthcare inclusive, cost-effective, and
accessible—for everyone," said Ahmad
Bani, CEO. "For this reason, we are working extremely
hard to advance and accelerate our product development efforts to
introduce new products that improve access to reproductive
After the U.S. Supreme Court overturned the Roe v. Wade ruling,
Wisp saw an unprecedented 3,000% surge in its emergency
contraceptive category within 24 hours.
"The decision fueled consumer demand for emergency
contraceptives from trusted and reliable sources," commented Dr.
Laura Purdy, MD and Wisp Medical
Director. "We're committed to continuing to offer patients safe,
accessible and convenient options."
For more information on Wisp please visit hellowisp.com.
About WELL Health Technologies
WELL is a practitioner focused digital health company whose
overarching objective is to positively impact health outcomes to
empower and support healthcare practitioners and their
patients. WELL has built an innovative practitioner
enablement platform that includes comprehensive end to end practice
management tools inclusive of virtual care and digital patient
engagement capabilities as well as Electronic Medical Records
(EMR), Revenue Cycle Management (RCM) and data protection
services. WELL uses this platform to power healthcare
practitioners both inside and outside of WELL's own omni-channel
patient services offerings. As such, WELL owns and operates
Canada's largest network of
outpatient medical clinics serving primary and specialized
healthcare services and is the provider of a leading
multi-national, multi-disciplinary telehealth offering. WELL
is publicly traded on the Toronto Stock Exchange under the symbol
"WELL" and trades on the OTCQX under the symbol
"WHTCF". To learn more about the Company, please
Wisp is a US technology leader and innovator whose objective is
to make reproductive and sexual healthcare inclusive,
cost-effective, and accessible for all. Wisp began by providing
discreet sexual health treatments online and has grown to offer a
comprehensive menu of products and telehealth services, including
prescription medication, OTC prevention, primary care
consultations, contraception delivery, and more. Wisp is a growing
and profitable company with run-rate revenues exceeding
$40M USD and is majority-owned by
WELL. To learn more, please visit www.hellowisp.com.
This news release may contain "Forward-Looking Information"
within the meaning of applicable Canadian securities laws,
including without limitation Wisp's response initiatives, and
commitment plans. Forward-Looking Information is based upon
several estimates and assumptions that, while considered reasonable
by management, are inherently subject to significant business,
economic and competitive uncertainties, and contingencies.
Forward-Looking Information generally can be identified by the use
of forward-looking words such as "may", "should", "will", "could",
"intend", "estimate", "plan", "anticipate", "expect", "believe" or
"continue", or the negative thereof or similar variations.
Forward-looking Information involves known and unknown risks,
uncertainties and other factors that may cause future results,
performance, or achievements to be materially different from the
estimated future results, performance or achievements expressed or
implied by such Forward Looking Information and, which are not
guarantees of future performance. WELL's statements expressed
or implied by Forward Looking Information are subject to several
risks, uncertainties, and conditions, many of which are outside of
WELL 's control, and undue reliance should not be placed on such
statements. Forward-Looking Information is qualified in their
entirety by inherent risks and uncertainties, including: direct and
indirect material adverse effects from the COVID-19 pandemic;
adverse market conditions; risks inherent in the primary healthcare
sector in general; regulatory and legislative changes; that future
results may vary from historical results; inability to obtain any
requisite future financing on suitable terms; any inability to
realize the expected benefits and synergies of acquisitions; that
market competition may affect the business, results and financial
condition of WELL and other risk factors identified in documents
filed by WELL under its profile at www.sedar.com, including its
most recent Annual Information Form. Except as required by
securities law, WELL does not assume any obligation to update or
revise any forward-looking information, whether as a result of new
information, events or otherwise.
View original content to download
SOURCE WELL Health Technologies Corp.